CELLULAR TARGETS OF POLYMAVIRUS TRANSFORMING PROTEINS
多瘤病毒转化蛋白的细胞靶标
基本信息
- 批准号:2874079
- 负责人:
- 金额:$ 1.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-07-16 至 2001-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: The study of cellular proteins that are specifically bound by
the tumor antigens of papovaviruses is proving increasingly important to our
understanding of human cancer, yielding important insights into signal
transduction pathways that play a role in cancer. Protein phosphatase 2A
(PP2A) and 14-3-3 proteins are highly conserved proteins ubiquitous in
eukaryotes. They are known to be involved in the control of cell
proliferation and are cellular targets of the papovavirus oncogene,
polyomavirus middle tumor antigen (MT), with which they form stable
complexes. The long range goal of this proposal is to understand both the
role(s) and regulation of PP2A and 14-3-3 proteins in MT functions,
especially MT-mediated transformation. The approach will be threefold: 1)
First, to directly investigate the role of PP2A activity in
PP2A/MT/pp60c-src complex formation and function, MT and pp60c-src
associated with catalytically inactive PP2A point mutants will be analyzed
biochemically and functionally to determine the type, location, and
functional importance of novel modifications. 2) Second, because
understanding MT regulation of PP2A requires further delineation of normal
PP2A regulation, three novel PP2A-associated proteins that are likely to be
involved in PP2A function and are also likely to shed light on MT effects on
PP2A will be identified and/or cloned and initially characterized. Each of
these proteins will be purified by immunoaffinity purification,
microsequenced, cloned if novel, and characterized biochemically and
functionally in regard to their involvement in PP2A and MT functions. 3)
Third, to determine if 14-3-3 proteins contribute to oncogenic
transformation by MT, perhaps by affecting association of other proteins
with MT, MT mutants defective in binding 14-3-3 proteins will be isolated
and analyzed for complex formation with cellular proteins and in
transformation assays.
描述:研究细胞蛋白质的特异性结合,
乳多空病毒的肿瘤抗原对我们的研究越来越重要,
了解人类癌症,产生重要的见解信号
在癌症中发挥作用的转导途径。 蛋白磷酸酶2A
(PP 2A)和14-3-3蛋白是在哺乳动物中普遍存在的高度保守蛋白。
真核生物 已知它们参与细胞的控制,
增殖并且是乳多空病毒癌基因的细胞靶,
多瘤病毒中间肿瘤抗原(MT),它们与之形成稳定的
配合物 本提案的长期目标是了解
PP 2A和14-3-3蛋白在MT功能中的作用和调节,
尤其是MT介导的转化。 该方法将包括三个方面:1)
首先,直接研究PP 2A活性在
PP 2A/MT/pp 60 c-src复合物的形成和功能,MT和pp 60 c-src
将分析与催化失活的PP 2A点突变体相关的
生物化学和功能,以确定类型,位置,
新修饰的功能重要性。 2)二是因为
了解PP 2A的MT调节需要进一步描述正常的
PP 2A调节,三种新的PP 2A相关蛋白,可能是
参与PP 2A功能,也可能揭示MT对
PP 2A将被鉴定和/或克隆并初步表征。 中的每
这些蛋白质将通过免疫亲和纯化来纯化,
微测序,如果是新的,则克隆,并进行生物化学表征,
就其参与PP 2A和MT功能而言,在功能上是不同的。 第三章
第三,为了确定14-3-3蛋白是否有助于致癌,
通过MT转化,可能通过影响其他蛋白质的结合
使用MT,将分离出在结合14-3-3蛋白方面有缺陷的MT突变体
并分析与细胞蛋白质的复合物形成情况,并在
转化测定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID C PALLAS其他文献
DAVID C PALLAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID C PALLAS', 18)}}的其他基金
CELLULAR TARGETS OF POLYOMAVIRUS TRANSFORMING PROTEINS
多瘤病毒转化蛋白的细胞靶标
- 批准号:
2911248 - 财政年份:1992
- 资助金额:
$ 1.77万 - 项目类别:
CELLULAR TARGETS OF POLYMAVIRUS TRANSFORMING PROTEINS
多瘤病毒转化蛋白的细胞靶标
- 批准号:
2856323 - 财政年份:1992
- 资助金额:
$ 1.77万 - 项目类别:
PP2A AND POLYOMAVIRUS TUMOR ANTIGEN FUNCTIONS
PP2A 和多瘤病毒肿瘤抗原功能
- 批准号:
2098059 - 财政年份:1992
- 资助金额:
$ 1.77万 - 项目类别:
ROLE OF PP2A IN POLYOMAVIRUS TUMOR ANTIGEN FUNCTIONS
PP2A 在多瘤病毒肿瘤抗原功能中的作用
- 批准号:
3201646 - 财政年份:1992
- 资助金额:
$ 1.77万 - 项目类别:
Cellular Targets of Polyomavirus Transforming Proteins
多瘤病毒转化蛋白的细胞靶标
- 批准号:
6873061 - 财政年份:1992
- 资助金额:
$ 1.77万 - 项目类别:
Cellular Targets of Polyomavirus Transforming Proteins
多瘤病毒转化蛋白的细胞靶标
- 批准号:
6872828 - 财政年份:1992
- 资助金额:
$ 1.77万 - 项目类别:
PP2A AND POLYOMAVIRUS TUMOR ANTIGEN FUNCTIONS
PP2A 和多瘤病毒肿瘤抗原功能
- 批准号:
2098060 - 财政年份:1992
- 资助金额:
$ 1.77万 - 项目类别:
相似国自然基金
miR-29a "targets" PPAR δ对心力衰竭的作用及作为潜在标志物的研究
- 批准号:81371895
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
HMA domain proteins as conserved targets of pathogens that exploit plasmodesmata
HMA 结构域蛋白作为利用胞间连丝的病原体的保守靶标
- 批准号:
BB/X016056/1 - 财政年份:2024
- 资助金额:
$ 1.77万 - 项目类别:
Research Grant
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 1.77万 - 项目类别:
Collaborative R&D
Developmental mechanisms specifying vagal innervation of organ targets
指定器官目标迷走神经支配的发育机制
- 批准号:
10752553 - 财政年份:2024
- 资助金额:
$ 1.77万 - 项目类别:
Finding the targets of natural products in complex botanical extracts.
寻找复杂植物提取物中天然产物的靶标。
- 批准号:
LP230100225 - 财政年份:2024
- 资助金额:
$ 1.77万 - 项目类别:
Linkage Projects
Four-stranded fungal fatality: Unveiling G-quadruplexes as future antifungal targets
四链真菌死亡:揭示 G-四链体作为未来抗真菌靶点
- 批准号:
BB/Y005058/1 - 财政年份:2024
- 资助金额:
$ 1.77万 - 项目类别:
Research Grant
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
- 批准号:
10110204 - 财政年份:2024
- 资助金额:
$ 1.77万 - 项目类别:
Launchpad
Using patient-led genetics to identify new therapeutic targets in metastatic cholangiocarcinoma
利用患者主导的遗传学来确定转移性胆管癌的新治疗靶点
- 批准号:
EP/Y028546/1 - 财政年份:2024
- 资助金额:
$ 1.77万 - 项目类别:
Fellowship
Breaking the Barrier: Mapping protein interactions in the bacterial outer membrane as targets for new antimicrobials
打破障碍:绘制细菌外膜中的蛋白质相互作用作为新抗菌药物的目标
- 批准号:
MR/Y012453/1 - 财政年份:2024
- 资助金额:
$ 1.77万 - 项目类别:
Research Grant
Identifying novel & repurposing drug targets for Atrial Fibrillation MEDicines
识别小说
- 批准号:
EP/Z000211/1 - 财政年份:2024
- 资助金额:
$ 1.77万 - 项目类别:
Research Grant
Develop the novel targets and immunotherapy-combination agents through targeting nuclear transport receptor
以核转运受体为靶点开发新靶点和免疫治疗联合药物
- 批准号:
24K13116 - 财政年份:2024
- 资助金额:
$ 1.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




